How much does a box of Vigabatrin cost?
Vigabatrin is an anti-epileptic drug mainly used to treat refractory epilepsy, especially infantile spasms (West syndrome). It increases the concentration of GABA in the brain by inhibiting the activity of γ-aminobutyric acid (GABA) transaminase, thereby reducing nerve excitation and inhibiting epileptic seizures. This mechanism allows Vigabatrin to show better efficacy in many cases where traditional drugs are ineffective, especially for infants and young children with epilepsy and other refractory epilepsy types.

Vigabatrin is currently on the market in China and has been included in medical insurance. 500mg*30bags are priced at around more than one thousand yuan. Please consult the local hospital pharmacy for specific domestic prices and medical insurance reimbursement. In addition, the cheaper ones include original drugs from Hong Kong, China, with the specification of 500mg*100 bags and the price is about more than a thousand yuan. The cheaper foreign generic drugs of the same specifications cost about a few hundred yuan, and the ingredients of the drugs are basically the same.
Vibatrin is usually taken orally aspowder, and the dosage is adjusted according to the patient's age, weight and condition. For infantile spasms, the starting dose is usually lower and gradually increased to the ideal therapeutic dose. In adult patients, higher doses may be used to control complex partial epilepsy. During treatment, doctors will regularly monitor patient response to ensure efficacy and minimize side effects.
In terms of side effects, long-term use of Vigabatrin may cause visual field defects, which is one of its most serious adverse reactions. Visual field defects are usually irreversible and may occur during the initial period of medication or after long-term use, so patients need to undergo regular vision examinations during treatment. In addition, common side effects include drowsiness, fatigue, mood changes, etc. Because of these side effects, the use of Vigabatrin needs to be carefully weighed against the risks and benefits, and done under close supervision by a doctor.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)